BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Neely RJ. Evolution of fit-for-purpose biomarker validations: an LBA perspective. Bioanalysis 2018;10:905-7. [DOI: 10.4155/bio-2017-0267] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Piccoli SP, Garofolo F. Biomarker assay validation. Bioanalysis 2018;10:889-91. [DOI: 10.4155/bio-2018-0127] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
2 Zhao Y, Gu H, Postelnek J, DeMichele M, Yuan L, Zhang YJ, Zeng J. Fit-for-purpose protein biomarker assay validation strategies using hybrid immunocapture-liquid chromatography-tandem-mass spectrometry platform: Quantitative analysis of total soluble cluster of differentiation 73. Anal Chim Acta 2020;1126:144-53. [PMID: 32736718 DOI: 10.1016/j.aca.2020.06.023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]